Shigematsu H - Search Results

1

Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis.

Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, Suzuki M, Miyajima K, Zhou X, Bekele BN, Gazdar AF, Wistuba II. Takahashi T, et al. Among authors: shigematsu h. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6126-33. doi: 10.1158/1078-0432.CCR-04-0579. Clin Cancer Res. 2004. PMID: 15447999

2

Aberrant methylation of SPARC in human lung cancers.

Suzuki M, Hao C, Takahashi T, Shigematsu H, Shivapurkar N, Sathyanarayana UG, Iizasa T, Fujisawa T, Hiroshima K, Gazdar AF. Suzuki M, et al. Among authors: shigematsu h. Br J Cancer. 2005 Mar 14;92(5):942-8. doi: 10.1038/sj.bjc.6602376. Br J Cancer. 2005. Retraction in: Br J Cancer. 2013 Feb 19;108(3):744. doi: 10.1038/bjc.2013.68 PMID: 15756262 Free PMC article. Retracted.

3

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF. Sathyanarayana UG, et al. Among authors: shigematsu h. Clin Cancer Res. 2003 Dec 15;9(17):6389-94. Clin Cancer Res. 2003. PMID: 14695139

4

Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.

Sathyanarayana UG, Padar A, Suzuki M, Maruyama R, Shigematsu H, Hsieh JT, Frenkel EP, Gazdar AF. Sathyanarayana UG, et al. Among authors: shigematsu h. Clin Cancer Res. 2003 Dec 15;9(17):6395-400. Clin Cancer Res. 2003. PMID: 14695140

5

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.

Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. Shivapurkar N, et al. Among authors: shigematsu h. Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041. Int J Cancer. 2004. PMID: 14999791

6

DNA methylation profiles of lymphoid and hematopoietic malignancies.

Takahashi T, Shivapurkar N, Reddy J, Shigematsu H, Miyajima K, Suzuki M, Toyooka S, Zöchbauer-Müller S, Drach J, Parikh G, Zheng Y, Feng Z, Kroft SH, Timmons C, McKenna RW, Gazdar AF. Takahashi T, et al. Among authors: shigematsu h. Clin Cancer Res. 2004 May 1;10(9):2928-35. doi: 10.1158/1078-0432.ccr-03-0716. Clin Cancer Res. 2004. Retraction in: Clin Cancer Res. 2013 Jan 1;19(1):307. doi: 10.1158/1078-0432.CCR-12-3679 PMID: 15131027 Retracted.

7

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies.

Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Shigematsu H, et al. Int J Cancer. 2005 Feb 10;113(4):600-4. doi: 10.1002/ijc.20622. Int J Cancer. 2005. PMID: 15472908

8

Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection.

Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, Gazdar AF. Suzuki M, et al. Among authors: shigematsu h. Oncogene. 2005 Feb 10;24(7):1302-8. doi: 10.1038/sj.onc.1208263. Oncogene. 2005. Retraction in: Oncogene. 2014 May 22;33(21):2814. doi: 10.1038/onc.2014.100 PMID: 15592515 Retracted.

9

Aberrant methylation of Reprimo in human malignancies.

Takahashi T, Suzuki M, Shigematsu H, Shivapurkar N, Echebiri C, Nomura M, Stastny V, Augustus M, Wu CW, Wistuba II, Meltzer SJ, Gazdar AF. Takahashi T, et al. Among authors: shigematsu h. Int J Cancer. 2005 Jul 1;115(4):503-10. doi: 10.1002/ijc.20910. Int J Cancer. 2005. Retraction in: Int J Cancer. 2013 Jan 15;132(2):498. doi: 10.1002/ijc.27882 PMID: 15700311 Retracted.

10

Aberrant methylation of Reprimo in lung cancer.

Suzuki M, Shigematsu H, Takahashi T, Shivapurkar N, Sathyanarayana UG, Iizasa T, Fujisawa T, Gazdar AF. Suzuki M, et al. Among authors: shigematsu h. Lung Cancer. 2005 Mar;47(3):309-14. doi: 10.1016/j.lungcan.2004.08.006. Lung Cancer. 2005. Retraction in: Lung Cancer. 2014 Aug;85(2):337. doi: 10.1016/j.lungcan.2014.05.004 PMID: 15713514 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

869 results

Search Page

Filters